Loading stock…

Colgate-Palmolive Company (CL) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

CLColgate-Palmolive

Revenue FY25$20.4B

GROWTH RATING↗

WEAK28 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+4%5

Revenue, next 1Y+5%4

Revenue, next 3Y, CAGR+4%3

Revenue, next 5Y, CAGR+3%3

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+48%9

EPS growth, FY27E+5%5

EPS growth, FY28E+6%5

GROWTH ASSESSMENT

STRENGTHS

Earnings are set to grow in step with sales (EPS about 6%/yr vs revenue 4%/yr).

WATCH

Revenue grew 4%/yr over the last 3 years and is set to keep growing around 4%/yr.

WEAKNESSES

Growth is the weak spot here, trailing 72% of companies worldwide.

Revenue is set to grow 4%/yr over the next 3 years, behind most of the market.3/10

Over five years revenue is set to grow 3%/yr, behind 70% of companies worldwide.3/10

BOTTOM LINE

Margin Expander

Growth is a weak point here. The one thing to watch: forward revenue growth trails the market.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE55 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-2%7

3-month return-8%4

YTD return+12%7

MID & LONG-TERM▾SCORE

% of 52-week high89%8

1-year return+13%6

3-year return+35%5

5-year return+30%5

MOMENTUM ASSESSMENT

STRENGTHS

It's up 13% over the past year, but 11% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (-2%) and so far this year (+12%).

WATCH

Average long-term results. Multi-year returns are middling (+35% over three years and +30% over five), roughly average for the market.

Returns sit at the market level over three months (-8%).

WEAKNESSES

None flagged.

BOTTOM LINE

Fresh Momentum

Short-term returns are strong but the long track record is thin. Momentum is building — confirmation from longer horizons would strengthen the case.

04Value

Are you paying a fair price for it?

Stop guessing on Colgate-Palmolive. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

CLColgate-Palmolive

Revenue FY25$20.4B

GROWTH RATING↗

WEAK28 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+4%5

Revenue, next 1Y+5%4

Revenue, next 3Y, CAGR+4%3

Revenue, next 5Y, CAGR+3%3

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+48%9

EPS growth, FY27E+5%5

EPS growth, FY28E+6%5

GROWTH ASSESSMENT

STRENGTHS

Earnings are set to grow in step with sales (EPS about 6%/yr vs revenue 4%/yr).

WATCH

Revenue grew 4%/yr over the last 3 years and is set to keep growing around 4%/yr.

WEAKNESSES

Growth is the weak spot here, trailing 72% of companies worldwide.

Revenue is set to grow 4%/yr over the next 3 years, behind most of the market.3/10

Over five years revenue is set to grow 3%/yr, behind 70% of companies worldwide.3/10

BOTTOM LINE

Margin Expander

Growth is a weak point here. The one thing to watch: forward revenue growth trails the market.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE55 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-2%7

3-month return-8%4

YTD return+12%7

MID & LONG-TERM▾SCORE

% of 52-week high89%8

1-year return+13%6

3-year return+35%5

5-year return+30%5

MOMENTUM ASSESSMENT

STRENGTHS

It's up 13% over the past year, but 11% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (-2%) and so far this year (+12%).

WATCH

Average long-term results. Multi-year returns are middling (+35% over three years and +30% over five), roughly average for the market.

Returns sit at the market level over three months (-8%).

WEAKNESSES

None flagged.

BOTTOM LINE

Fresh Momentum

Short-term returns are strong but the long track record is thin. Momentum is building — confirmation from longer horizons would strengthen the case.

04Value

Are you paying a fair price for it?

Stop guessing on Colgate-Palmolive. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Colgate-Palmolive Company

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on Colgate-Palmolive. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on Colgate-Palmolive. Get the full investment case.

Premium